Louisiana Launches AI Initiative to Accelerate ALS Drug Discovery
Louisiana Launches AI Initiative to Accelerate ALS Drug Discovery
Answer ALS launches LADDIA, a Louisiana-based AI-driven initiative with institutions like Tulane and GATC to accelerate ALS drug discovery using large datasets and innovative AI models, aiming to identify therapeutic targets and position Louisiana as a leader in neurodegenerative disease research.
